- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Lennox-Gastaut syndrome Dravet syndrome
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1.5MB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 118KB)
Cannabidiol – November 2020
Cannabidiol: Oral solution 100 mg per ml, 100 ml; Epidyolex®
Last updated
5 March 2021